Pharma Latch

Pharma Latch have developed a series of innovative HCP and self-administration intradermal injection devices, based on a core platform technology. Our devices ensure consistent needle-depth penetration and complete dose delivery to the intended compartment and can inject high volume and viscosity formulations (up to: 3 mL, 60 cP).